Search Results - "Rieder, C R M"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson’s disease by Rieck, M, Schumacher-Schuh, A F, Altmann, V, Callegari-Jacques, S M, Rieder, C R M, Hutz, M H

    Published in The pharmacogenomics journal (01-01-2018)
    “…Levodopa is the most used drug to treat motor symptoms in Parkinson’s disease (PD). However, dopaminergic side effects such as nausea and vomiting may occur…”
    Get full text
    Journal Article
  2. 2

    Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson’s disease patients by Schumacher-Schuh, A F, Altmann, V, Rieck, M, Tovo-Rodrigues, L, Monte, T L, Callegari-Jacques, S M, Medeiros, M S, Rieder, C R M, Hutz, M H

    Published in The pharmacogenomics journal (01-06-2014)
    “…Levodopa is the most effective symptomatic therapy for Parkinson’s disease, but its chronic use could lead to chronic adverse outcomes, such as motor…”
    Get full text
    Journal Article
  3. 3

    Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study by Monte, T. L., Rieder, C. R. M., Tort, A. B., Rockenback, I., Pereira, M. L., Silveira, I., Ferro, A., Sequeiros, J., Jardim, L. B.

    Published in Acta neurologica Scandinavica (01-03-2003)
    “…Context – Machado‐Joseph Disease (MJD/SCA3) is an autosomal dominant spinocerebellar degeneration that evolves to disability and death. Experimental data have…”
    Get full text
    Journal Article
  4. 4

    A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3) by Kieling, C., Rieder, C. R. M., Silva, A. C. F., Saute, J. A. M., Cecchin, C. R., Monte, T. L., Jardim, L. B.

    Published in European journal of neurology (01-04-2008)
    “…Spinocerebellar ataxias (SCAs) are characterized by a heterogeneous set of clinical manifestations. Our aims were to assess the neurological features of SCA3,…”
    Get full text
    Journal Article
  5. 5

    Intrafamilial variability of Parkinson phenotype in SCAs: Novel cases due to SCA2 and SCA3 expansions by Socal, M.P, Emmel, V.E, Rieder, C.R.M, Hilbig, A, Saraiva-Pereira, M.L, Jardim, L.B

    Published in Parkinsonism & related disorders (01-06-2009)
    “…Abstract Background Parkinson's disease (PD) has been related to mutations associated with spinocerebellar ataxias (SCA); the frequency of the diagnosis of…”
    Get full text
    Journal Article
  6. 6

    Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3 by Siebert, M, Donis, K.C, Socal, M, Rieder, C.R.M, Emmel, V.E, Vairo, F, Michelin-Tirelli, K, França, M, D’Abreu, A.C, Bettencourt, C, Lima, M, Lopes Cendes, I, Saraiva-Pereira, M.L, Jardim, L.B

    Published in Parkinsonism & related disorders (01-02-2012)
    “…Abstract Machado-Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3) may rarely presents a parkinsonian phenotype. Considering that mutations in the…”
    Get full text
    Journal Article
  7. 7

    Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy by Manfro, R.C., Vedolin, L., Cantarelli, M., Oppitz, P., Antunes, A.C.M., Rieder, C.R.M.

    Published in Transplant infectious disease (01-04-2009)
    “…Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells by Rieder, C R M, Williams, A C, Ramsden, D B

    “…Increased dopamine catabolism may be associated with oxidative stress and neuronal cell death in Parkinson's disease. The present study was carried out to…”
    Get full text
    Journal Article
  10. 10

    Human brain cytochrome P450 1B1: immunohistochemical localization in human temporal lobe and induction by dimethylbenz( a)anthracene in astrocytoma cell line (MOG-G-CCM) by Rieder, Carlos R.M, Parsons, Richard B, Fitch, Nicholas J.S, Williams, Adrian C, Ramsden, David B

    Published in Neuroscience letters (01-01-2000)
    “…CYP1B1, a new member of human cytochrome P450 family 1, is involved in the xenobiotic detoxification metabolism and possibly activation of numerous…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Cytochrome P450 1B1 mRNA in the human central nervous system by Rieder, C R, Ramsden, D B, Williams, A C

    Published in Molecular pathology (01-06-1998)
    “…AIMS: To study the expression of CYP1B1 in a variety of human and rat cell lines as a means of identifying a new tool for the investigation of gene regulation…”
    Get full text
    Journal Article